Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons

Neuropharmacology

Volumn 55, Issue 7, 2008, Pages 1114-1120

  Bachis, Alessia ^a   Mallei, Alessandra ^a   Cruz, Maria Idalia ^a   Wellstein, Anton ^b   Mocchetti, Italo ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cerebral cortex; Desipramine (DMI); FGF binding protein; Fibroblast growth factor 2 (FGF2); Fluoxetine; Hippocampus

Indexed keywords

ANTIDEPRESSANT AGENT; BASIC FIBROBLAST GROWTH FACTOR; CHAPERONE; DESIPRAMINE; FIBROBLAST GROWTH FACTOR BINDING PROTEIN; FLUOXETINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CATECHOLAMINE NERVE CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; HIPPOCAMPUS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LONG TERM CARE; MALE; MOOD DISORDER; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS; BLOTTING, WESTERN; CELL NUCLEUS; CYTOSOL; DESIPRAMINE; FIBROBLAST GROWTH FACTOR 2; FLUVOXAMINE; IMMUNOHISTOCHEMISTRY; ISOMERISM; MALE; NEURONS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, FIBROBLAST GROWTH FACTOR; SEROTONIN UPTAKE INHIBITORS;

EID: 54049086896     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.07.014     Document Type: Article

References (55)

1. Abuharbeid S., Czubayko F., and Aigner A. The fibroblast growth factor-binding protein FGF-BP. Int. J. Biochem. Cell Biol. 38 9 (2006) 1463-1468
2. Bachis A., Aden S.A., Nosheny R.L., Andrews P.M., and Mocchetti I. Axonal transport of human immunodeficiency virus type 1 envelope glycoprotein 120 is found in association with neuronal apoptosis. J. Neurosci. 26 25 (2006) 6771-6780
3. Baguma-Nibasheka M., Li A.W., and Murphy P.R. The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of FGF-2 and delays cell cycle progression in C6 glioma cells. Mol. Cell. Endocrinol. 267 1-2 (2007) 127-136
4. Bal-Klara A., and Bird M.M. The effects of various antidepressant drugs on the fine-structure of neurons of the cingulate cortex in culture. Neuroscience 37 3 (1990) 685-692
5. Bland S.T., Tamlyn J.P., Barrientos R.M., Greenwood B.N., Watkins L.R., Campeau S., Day H.E., and Maier S.F. Expression of fibroblast growth factor-2 and brain-derived neurotrophic factor mRNA in the medial prefrontal cortex and hippocampus after uncontrollable or controllable stress. Neuroscience 144 4 (2007) 1219-1228
6. Colangelo A.M., Johnson P.F., and Mocchetti I. Beta-adrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein delta. Proc. Natl. Acad. Sci. U.S.A. 95 18 (1998) 10920-10925
7. Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., and Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. U.S.A. 98 22 (2001) 12796-12801
8. Czubayko F., Liaudet-Coopman E.D., Aigner A., Tuveson A.T., Berchem G.J., and Wellstein A. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat. Med. 3 10 (1997) 1137-1140
9. Delrieu I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism. FEBS Lett. 468 1 (2000) 6-10
10. Evans S.J., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., Lopez J.F., Thompson R.C., Meng F., Stead J.D., Walsh D.M., Myers R.M., Bunney W.E., Watson S.J., Jones E.G., and Akil H. Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. U.S.A. 101 43 (2004) 15506-15511
11. Ferguson I.A., and Johnson E.M.J. Fibroblast growth factor receptor-bearing neurons in the CNS: identification by receptor-mediated retrograde transport. J. Comp. Neurol. 22 313 (1991) 693-706
12. Ferrari G., Minozzi M.C., Toffano G., Leon A., and Skaper S.D. Basic fibroblast growth factor affects the survival and development of mesencephalic neurons in culture. Adv. Exp. Med. Biol. 265 (1990) 93-99
13. Figiel M., Maucher T., Rozyczka J., Bayatti N., and Engele J. Regulation of glial glutamate transporter expression by growth factors. Exp. Neurol. 183 1 (2003) 124-135
14. Follesa P., Gale K., and Mocchetti I. Regional and temporal pattern of expression of nerve growth factor and basic fibroblast growth factor mRNA in rat brain following electroconvulsive shock. Exp. Neurol. 127 1 (1994) 37-44
15. Fukui S., Nawashiro H., Otani N., Ooigawa H., Nomura N., Yano A., Miyazawa T., Ohnuki A., Tsuzuki N., Katoh H., Ishihara S., and Shima K. Nuclear accumulation of basic fibroblast growth factor in human astrocytic tumors. Cancer 97 12 (2003) 3061-3067
16. Ganat Y., Soni S., Chacon M., Schwartz M.L., and Vaccarino F.M. Chronic hypoxia up-regulates fibroblast growth factor ligands in the perinatal brain and induces fibroblast growth factor-responsive radial glial cells in the sub-ependymal zone. Neuroscience 112 4 (2002) 977-991
17. Gaughran F., Payne J., Sedgwick P.M., Cotter D., and Berry M. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res. Bull. 70 3 (2006) 221-227
18. Gomez-Pinilla F., Lee J.W., and Cotman C.W. Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection. J. Neurosci. 12 1 (1992) 345-355
19. Gould E., and Tanapat P. Stress and hippocampal neurogenesis. Biol. Psychiatry 46 11 (1999) 1472-1479
20. Grothe C., Schulze A., Semkova I., Muller-Ostermeyer F., Rege A., and Wewetzer K. The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro. Neuroscience 100 1 (2000) 73-86
21. Grothe C., and Timmer M. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system. Brain Res. Rev. 54 1 (2007) 80-91
22. Gurvits T.V., Shenton M.E., Hokama H., Ohta H., Lasko N.B., Gilbertson M.W., Orr S.P., Kikinis R., Jolesz F.A., McCarley R.W., and Pitman R.K. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol. Psychiatry 40 11 (1996) 1091-1099
23. Hayes V.Y., Isackson P.J., Fabrazzo M., Follesa P., and Mocchetti I. Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: contrasting anatomical and cellular localization. Exp. Neurol. 132 1 (1995) 33-41
24. Jin K., LaFevre-Bernt M., Sun Y., Chen S., Gafni J., Crippen D., Logvinova A., Ross C.A., Greenberg D.A., and Ellerby L.M. FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 102 50 (2005) 18189-18194
25. Korada S., Zheng W., Basilico C., Schwartz M.L., and Vaccarino F.M. Fibroblast growth factor 2 is necessary for the growth of glutamate projection neurons in the anterior neocortex. J. Neurosci. 22 3 (2002) 863-875
26. Leadbeater W.E., Gonzalez A.M., Logaras N., Berry M., Turnbull J.E., and Logan A. Intracellular trafficking in neurones and glia of fibroblast growth factor-2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex. J. Neurochem. 96 4 (2006) 1189-1200
27. Li A.J., Suzuki S., Suzuki M., Mizukoshi E., and Imamura T. Fibroblast growth factor-2 increases functional excitatory synapses on hippocampal neurons. Eur. J. Neurosci. 16 7 (2002) 1313-1324
28. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., Wihler C., Koliatsos V.E., and Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. U.S.A. 96 26 (1999) 15239-15244
29. Ma X., Dang X., Claus P., Hirst C., Fandrich R.R., Jin Y., Grothe C., Kirshenbaum L.A., Cattini P.A., and Kardami E. Chromatin compaction and cell death by high molecular weight FGF-2 depend on its nuclear localization, intracrine ERK activation, and engagement of mitochondria. J. Cell. Physiol. 213 3 (2007) 690-698
30. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20 24 (2000) 9104-9110
31. Mallei A., Shi B., and Mocchetti I. Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol. Pharmacol. 61 5 (2002) 1017-1024
32. Maragnoli M.E., Fumagalli F., Gennarelli M., Racagni G., and Riva M.A. Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain. Biol. Psychiatry 55 11 (2004) 1095-1102
33. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87 3 (2007) 873-904
34. Menkes D.B., Rasenick M.M., Wheeler M.A., and Bitensky M.W. Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment. Science 219 4580 (1983) 65-67
35. Mocchetti I., Rabin S.J., Colangelo A.M., Whittemore S.R., and Wrathall J.R. Increased basic fibroblast growth factor expression following contusive spinal cord injury. Exp. Neurol. 141 1 (1996) 154-164
36. Mocchetti I., Spiga G., Hayes V.Y., Isackson P.J., and Colangelo A. Glucocorticoids differentially increase nerve growth factor and basic fibroblast growth factor expression in the rat brain. J. Neurosci. 16 6 (1996) 2141-2148
37. Mohapel P., Frielingsdorf H., Haggblad J., Zachrisson O., and Brundin P. Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience 132 3 (2005) 767
38. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 11 (1995) 7539-7547
39. Nolan C.L., Moore G.J., Madden R., Farchione T., Bartoi M., Lorch E., Stewart C.M., and Rosenberg D.R. Prefrontal cortical volume in childhood-onset major depression: preliminary findings. Arch. Gen. Psychiatry 59 2 (2002) 173-179
40. Nosheny R.L., Bachis A., Acquas E., and Mocchetti I. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Eur. J. Neurosci. 20 11 (2004) 2857-2864
41. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U.S.A. 95 22 (1998) 13290-13295
42. Peng H., Moffett J., Myers J., Fang X., Stachowiak E.K., Maher P., Kratz E., Hines J., Fluharty S.J., Mizukoshi E., Bloom D.C., and Stachowiak M.K. Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol. Biol. Cell 12 2 (2001) 449-462
43. Perera T.D., Coplan J.D., Lisanby S.H., Lipira C.M., Arif M., Carpio C., Spitzer G., Santarelli L., Scharf B., Hen R., Rosoklija G., Sackeim H.A., and Dwork A.J. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J. Neurosci. 27 18 (2007) 4894-4901
44. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 5634 (2003) 805-809
45. Sheline Y.I., Gado M.H., and Kraemer H.C. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 160 8 (2003) 1516-1518
46. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 93 9 (1996) 3908-3913
47. Sieber-Blum M., and Ren Z. Norepinephrine transporter expression and function in noradrenergic cell differentiation. Mol. Cell. Biochem. 212 1-2 (2000) 61-70
48. Sorensen V., Nilsen T., and Wiedlocha A. Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays 28 5 (2006) 504-514
49. Szebenyi G., Dent E.W., Callaway J.L., Seys C., Lueth H., and Kalil K. Fibroblast growth factor-2 promotes axon branching of cortical neurons by influencing morphology and behavior of the primary growth cone. J. Neurosci. 21 11 (2001) 3932-3941
50. Tassi E., Al-Attar A., Aigner A., Swift M.R., McDonnell K., Karavanov A., and Wellstein A. Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein. J. Biol. Chem. 276 43 (2001) 40247-40253
51. Tassi E., Henke R.T., Bowden E.T., Swift M.R., Kodack D.P., Kuo A.H., Maitra A., and Wellstein A. Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. Cancer Res. 66 2 (2006) 1191-1198
52. Tassi E., Walter S., Aigner A., Cabal-Manzano R.H., Ray R., Reier P.J., and Wellstein A. Effects on neurite outgrowth and cell survival of a secreted fibroblast growth factor binding protein upregulated during spinal cord injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 2 (2007) R775-R783
53. Woodward W.R., Nishi R., Meshul C.K., Williams T.E., Coulombe M., and Eckenstein F.P. Nuclear and cytoplasmic localization of basic fibroblast growth factor in astrocytes and CA2 hippocampal neurons. J. Neurosci. 12 1 (1992) 142-152
54. Wu D.Q., Kan M.K., Sato G.H., Okamoto T., and Sato J.D. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem. 266 25 (1991) 16778-16785
55. Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., Cohen H., Kipnis J., and Schwartz M. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 9 2 (2006) 268-275